Iqstel files preliminary information statement draft on Nasdaq-related share issuance approvals

iQSTEL, Inc.

iQSTEL, Inc.

IQST

0.00

  • Iqstel shareholders authorized issuances above 19.99% of outstanding common stock tied to a USD 50 million M2B equity line.
  • Authorization also covers common stock issued on conversion or true-up adjustments under Series D Preferred Stock linked to ADI Funding arrangements.
  • Shareholders authorized employment agreement changes shifting annual equity incentives to up to 50000 Series B Preferred Shares per executive.
  • They also authorized FY-2025 long-term equity awards of 20000 Series B Preferred Shares to Leandro Jose Iglesias.
  • FY-2025 awards include 14000 Series B Preferred Shares to Álvaro Quintana Cardona.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iqstel Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001663577-26-000206), on July 10, 2026, and is solely responsible for the information contained therein.